Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

Anti-angiogenic therapy with bevacizumab is a widely used therapeutic option for recurrent glioblastoma (GBM). Nevertheless, the therapeutic response remains highly heterogeneous among GBM patients with discordant outcomes. Recent data have shown that radiomics, an advanced recent imaging analysis m...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diagnostics (Basel)
Asıl Yazarlar: Ammari, Samy, Sallé de Chou, Raoul, Assi, Tarek, Touat, Mehdi, Chouzenoux, Emilie, Quillent, Arnaud, Limkin, Elaine, Dercle, Laurent, Hadchiti, Joya, Elhaik, Mickael, Moalla, Salma, Khettab, Mohamed, Balleyguier, Corinne, Lassau, Nathalie, Dumont, Sarah, Smolenschi, Cristina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8305059/
https://ncbi.nlm.nih.gov/pubmed/34359346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11071263
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller